MedTrace Logo

A Web-based Program to Help Caregivers of Lung Patients Learn About Available Supportive Care Resources

NCT06383988 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 216

Last updated 2026-04-13

No results posted yet for this study

Summary

Clinical trial that tests the feasibility of a web based caregiver support resource, along with caregiver navigation sessions for caregivers of patients with stage II-IV lung cancer. The Caregiver Oncology Needs Evaluation Tool (CONNECT) is a novel web-based intervention designed for the community oncology setting, to systematically connect lung cancer caregivers with tailored supportive care resources. Lung cancer caregivers provide critical and challenging care for their loved ones and are at risk for their own negative psychosocial and physical outcomes. Implementing the CONNECT program along with caregiver navigation may provide additional support to caregivers of patients with stage II-IV lung cancer.

Conditions

  • Stage II Lung Cancer
  • Stage III Lung Cancer
  • Stage IV Lung Cancer

Interventions

OTHER

Support for Caregiver - Generic List

Receive a generic resource list

OTHER

Support for Caregiver - Personalized List

Receive personalized resource list

OTHER

Internet-Based Intervention - CONNECT

Receive access to CONNECT tool

BEHAVIORAL

Patient Navigation

Complete calls with caregiver navigator

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Kathryn Weaver, PhD · Wake Forest University Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-11-11
Primary Completion
2026-06-30
Completion
2026-07-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06383988 on ClinicalTrials.gov